| Literature DB >> 24252549 |
Victoria Borg Debono, Shiyuan Zhang, Chenglin Ye, James Paul, Aman Arya, Lindsay Hurlburt, Yamini Murthy, Lehana Thabane1.
Abstract
BACKGROUND: Methodologists have proposed the formation of a good research question to initiate the process of developing a research protocol that will guide the design, conduct and analysis of randomized controlled trials (RCTs), and help improve the quality of reporting such studies. Five constituents of a good research question based on the PICOT framing include: Population, Intervention, Comparator, Outcome, and Time-frame of outcome assessment. The aim of this study was to analyze if the presence a structured research question, in PICOT format, in RCTs used within a 2010 meta-analysis investigating the effectiveness of femoral nerve blocks after total knee arthroplasty, is independently associated with improved quality of reporting.Entities:
Year: 2013 PMID: 24252549 PMCID: PMC4175096 DOI: 10.1186/1471-2253-13-44
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Description of overall quality of reporting items
| 1. Title or Abstract | Identification as a randomized trial in the title and a structured summary of the trial design, methods, results, and conclusions. |
| 2. Background | Scientific background and explanation of rationale. |
| 3. Objectives | Specific objectives or hypotheses. |
| 4. Participants | Eligibility criteria for participants. |
| Settings and locations where the data were collected | |
| 5. Interventions | The interventions for each group with sufficient details to allow replication, including how and when they were actually administered. |
| 6. Outcomes* | Completely defined pre-specified primary and secondary outcome measures, including how and when they were assessed. |
| 7. Sample Size | How sample size was determined.When applicable, explanation of any interim analyses and stopping guidelines. |
| 8. Randomization: Sequence Generation | Method used to generate the random allocation sequenceType of randomisation; details of any restriction (such as blocking and block size). |
| 9. Randomization: Implementation | There is mention of: Who generated the random allocation sequence, who enrolled participants, and who assigned participants to interventions? |
| 10. Statistical Methods | Statistical methods used to compare groups for primary and secondary outcomes. |
| Methods for additional analyses, such as subgroup analyses and adjusted analyses. | |
| 11. Participants Flow | For each group, the numbers of participants who were randomly assigned, received intended treatment, and were analysed for the primary outcome. |
| For each group, losses and exclusions after randomisation, together with reasons. | |
| 12. Recruitment | Dates defining the periods of recruitment and follow-up |
| Why the trial ended or was stopped. | |
| 13. Baseline Data | A table showing baseline demographic and clinical characteristics for each group. |
| 14. Outcomes and Estimates | For each primary and secondary outcome, results for each group, and the estimated effect size and its precision (such as 95% confidence interval). |
| For binary outcomes, presentation of both absolute and relative effect sizes is recommended. | |
| 15. Harms | All important harms or unintended effects in each group |
*For the purpose of this study, our original 15 point OQRS was reduced to a 14 point score because one of the 15 items we initially assessed for was “objectives” and this was assessed as part of our PICOT score instead.
aThe descriptions of the reporting items were taken directly from the CONSORT 2010 [16].
Frequency of description of each PICOT element
| 21 | (18, 23) | |
| 23 | (15, 23) | |
| 19 | (15, 22) | |
| 12 | (7, 17) | |
| 4 | (1, 8) | |
| 2 | (0, 5) | |
CI: Confidence Interval.
*For item that has non-zero event, the 95% CI was approximated by assuming the number of events followed a Binomial distribution; for item that has zero event, the 95% CI was approximated by the rule of three [44].
Association between PICOT score and Overall Quality of Reporting Score (OQRS)
| | ||||||
|---|---|---|---|---|---|---|
| PICOT | 1.159 | (0.835, 1.608) | 0.378 | 1.267 | (0.984, 1.630) | 0.066 |
| Sample Sizeb | 0.998 | (0.991, 1.006) | 0.681 | 0.546 | (0.199, 1.498) | 0.240 |
| Impact Factor | 0.949 | (0.744, 1.209) | 0.67 | 0.915 | (0.690, 1.212) | 0.535 |
| Journal adopted CONSORT Statement at the time of data collection. | 0.898 | (0.646, 1.248) | 0.521 | 1.063 | (0.721, 1.568) | 0.757 |
| Funding reported | 1.241 | (0.817, 1.887) | 0.312 | 1.147 | (0.722, 1.823) | 0.562 |
CI: Confidence Interval; IRR: Incidence Rate Ratio.
aMaximum Possible Score for the Overall Quality of Reporting Score = 14.
bThe sample size variable was log(10) transformed. The value is an expression of the change in the average of the OQRS due to one unit increase in sample size in the log scale.
Association between PICOT score and Key Methodological Items Score (KMIS)
| | ||||||
|---|---|---|---|---|---|---|
| PICOT | 1.007 | (0.987, 1.027) | 0.492 | 1.061 | (0.515, 2.188) | 0.872 |
| Sample Sizeb | 1.746 | (0.677, 4.504) | 0.249 | 2.139 | (0.126, 36.243) | 0.598 |
| Impact Factor | 1.601 | (0.784, 3.269) | 0.196 | 2.037 | (0.739, 5.614) | 0.169 |
| Journal adopted CONSORT Statement at the time of data collection. | 0.909 | (0.359, 2.303) | 0.841 | 0.528 | (0.147, 1.900) | 0.329 |
| Funding reported | 2.051 | (0.731, 5.754) | 0.172 | 1.697 | (0.533, 5.408) | 0.371 |
CI: Confidence Interval; IRR: Incidence Rate Ratio.
aMaximum Possible Score for the Key Methodological Items Score = 3.
bThe sample size variable was log(10) transformed. The value is an expression of the change in the average of the KMIS due to one unit increase in sample size in the log scale.
Association between individual PICOT items and the outcomes (Overall Quality of Reporting Score (OQRS) and the Key Methodological Items Score (KMIS) )
| P – Population | 1.427 | (0.566, 3.593) | 0.451 |
| Sample sizec | 0.737 | (0.287, 1.894) | 0.527 |
| Impact factor | 0.939 | (0.714, 1.236) | 0.655 |
| Journal adopted CONSORT Statement at the time of data collection. | 0.954 | (0.665, 1.368) | 0.796 |
| Funding reported | 1.267 | (0.818, 1.962) | 0.290 |
| C - Control | 1.459 | (0.855, 2.490) | 0.166 |
| Sample sizec | 0.679 | (0.264, 1.750) | 0.423 |
| Impact factor | 0.921 | (0.699, 1.212) | 0.556 |
| Journal adopted CONSORT Statement at the time of data collection. | 0.871 | (0.604, 1.256) | 0.458 |
| Funding reported | 1.448 | (0.910, 2.304) | 0.119 |
| O - Outcome | 1.099 | (0.726, 1.664) | 0.655 |
| Sample sizec | 0.753 | (0.293, 1.939) | 0.557 |
| Impact factor | 0.915 | (0.691, 1.212) | 0.536 |
| Journal adopted CONSORT Statement at the time of data collection. | 0.972 | (0.648, 1.458) | 0.891 |
| Funding reported | 1.236 | (0.762, 2.008) | 0.391 |
| T- Timeframe | 1.320 | (0.818, 2.131) | 0.256 |
| Sample sizec | 0.611 | (0.215, 1.733) | 0.354 |
| Impact factor | 0.935 | (0.708, 1.236) | 0.638 |
| Journal adopted CONSORT Statement at the time of data collection. | 0.987 | (0.676, 1.440) | 0.945 |
| Funding reported | 1.234 | (0.790, 1.928) | 0.355 |
| P- Population | 0.726 | (0.085, 6.216) | 0.770 |
| Sample sizec | 2.548 | (0.194, 33.401) | 0.476 |
| Impact factor | 2.032 | (0.732, 5.641) | 0.173 |
| Journal adopted CONSORT Statement at the time of data collection. | 0.496 | (0.136, 1.812) | 0.289 |
| Funding reported | 1.811 | (0.624, 5.260) | 0.275 |
| C - Control | 2.068 | (0.386, 11.076) | 0.396 |
| Sample sizec | 1.674 | (0.127, 22.148) | 0.696 |
| Impact factor | 1.995 | (0.732, 5.436) | 0.177 |
| Journal adopted CONSORT Statement at the time of data collection. | 0.457 | (0.127, 1.641) | 0.230 |
| Funding reported | 2.130 | (0.665, 6.825) | 0.203 |
| O - Outcome | 0.948 | (0.277, 3.245) | 0.933 |
| Sample sizec | 2.418 | (0.189, 30.923) | 0.497 |
| Impact factor | 2.017 | (0.744, 5.470) | 0.168 |
| Journal adopted CONSORT Statement at the time of data collection. | 0.507 | (0.134, 1.919) | 0.317 |
| Funding reported | 1.823 | (0.506, 6.569) | 0.359 |
| T - Timeframe | 0.799 | (0.187, 3.403) | 0.761 |
| Sample sizec | 2.858 | (0.181, 45.059) | 0.455 |
| Impact factor | 1.973 | (0.725, 5.371) | 0.184 |
| Journal adopted CONSORT Statement at the time of data collection. | 0.514 | (0.151, 1.755) | 0.288 |
| Funding reported | 1.872 | (0.618, 5.668) | 0.267 |
CI: Confidence Interval; IRR: Incidence Rate Ratio.
aMaximum Possible Score for the Overall Quality of Reporting Score (OQRS) = 14.
Maximum Possible Score for the Key Methodological Items Score = 3.
cThe sample size variable was log(10) transformed. The value is an expression of the change in the average of the OQRS due to one unit increase in sample size in the log scale.
No individual analysis of the Intervention (I) component of the PICOT score was done because all studies reported their intervention when they described their research question.